BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23817164)

  • 21. Dimensions of delusional experience scale: a psychometric evaluation of a german version.
    Büche L; Gentner NC; Kaiser S; von Bock A; Grupe S; Joest K; Barthel A; Vedder H; Mundt C; Kronmüller KT
    Psychopathology; 2010; 43(3):189-96. PubMed ID: 20375541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric evaluation of the appearance anxiety inventory in adolescents with body dysmorphic disorder.
    Gumpert M; Rautio D; Monzani B; Jassi A; Krebs G; Fernández de la Cruz L; Mataix-Cols D; Jansson-Fröjmark M
    Cogn Behav Ther; 2024 May; 53(3):254-266. PubMed ID: 38174353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An examination of delusional thinking and cognitive styles in body dysmorphic disorder.
    Labuschagne I; Castle DJ; Dunai J; Kyrios M; Rossell SL
    Aust N Z J Psychiatry; 2010 Aug; 44(8):706-12. PubMed ID: 20636191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body image in patients with body dysmorphic disorder: evaluations of and investment in appearance, health/illness, and fitness.
    Didie ER; Kuniega-Pietrzak T; Phillips KA
    Body Image; 2010 Jan; 7(1):66-9. PubMed ID: 19942488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insight in body dysmorphic disorder (BDD) relative to obsessive-compulsive disorder (OCD) and psychotic disorders: Revisiting this issue in light of DSM-5.
    Toh WL; Castle DJ; Mountjoy RL; Buchanan B; Farhall J; Rossell SL
    Compr Psychiatry; 2017 Aug; 77():100-108. PubMed ID: 28651226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using theories of delusion formation to explain abnormal beliefs in Body Dysmorphic Disorder (BDD).
    Rossell SL; Labuschagne I; Dunai J; Kyrios M; Castle DJ
    Psychiatry Res; 2014 Mar; 215(3):599-605. PubMed ID: 24412353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychometric properties of the Nepean Belief Scale as a tool for assessing delusions in schizophrenia and related psychotic disorders.
    Rajendran P; Van Winssen C; Viswasam K; Tariq N; Espinoza D; Starcevic V; Brakoulias V
    Compr Psychiatry; 2022 Aug; 117():152337. PubMed ID: 35863256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID).
    Shankman SA; Funkhouser CJ; Klein DN; Davila J; Lerner D; Hee D
    Int J Methods Psychiatr Res; 2018 Mar; 27(1):. PubMed ID: 29034525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Body dysmorphic disorder].
    Schmoll D
    Fortschr Neurol Psychiatr; 2010 Jul; 78(7):394-401. PubMed ID: 20607639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a body dysmorphic disorder screener for DSM-5 (BDDS-5).
    Van Rood YR; Wyk van N; Böhringer S; van der Wee NJA; Möllmann A; Dingemans AE
    Compr Psychiatry; 2023 Nov; 127():152416. PubMed ID: 37688935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.
    Phillips KA; Menard W; Pagano ME; Fay C; Stout RL
    J Psychiatr Res; 2006 Mar; 40(2):95-104. PubMed ID: 16229856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial.
    Veale D; Anson M; Miles S; Pieta M; Costa A; Ellison N
    Psychother Psychosom; 2014; 83(6):341-53. PubMed ID: 25323062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is anorexia nervosa a delusional disorder? An assessment of eating beliefs in anorexia nervosa.
    Steinglass JE; Eisen JL; Attia E; Mayer L; Walsh BT
    J Psychiatr Pract; 2007 Mar; 13(2):65-71. PubMed ID: 17414681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale.
    Kaplan GB; Phillips KA; Vaccaro A; Eisen JL; Posternak MA; MacAskill HS
    Schizophr Res; 2006 Feb; 82(2-3):279-81. PubMed ID: 16406495
    [No Abstract]   [Full Text] [Related]  

  • 36. [Body dysmorphic disorder and psychosis. Case reports and discussion].
    Loréa N; Van Wijnendaele R
    Encephale; 2012 Feb; 38(1):37-41. PubMed ID: 22381722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Evaluation of the Body Dysmorphic Disorder Symptom Scale as a Measure of Treatment Response and Remission in Psychotherapy and Medication Trials.
    Summers BJ; Hoeppner SS; Beatty CC; Blais MA; Greenberg JL; Phillips KA; Wilhelm S
    Behav Ther; 2022 May; 53(3):521-534. PubMed ID: 35473654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of a transdiagnostic treatment for emotional disorders to body dysmorphic disorder: A randomized controlled trial.
    Mohajerin B; Bakhtiyar M; Olesnycky OS; Dolatshahi B; Motabi F
    J Affect Disord; 2019 Feb; 245():637-644. PubMed ID: 30445389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reality monitoring in patients with body dysmorphic disorder.
    Reese HE; McNally RJ; Wilhelm S
    Behav Ther; 2011 Sep; 42(3):387-98. PubMed ID: 21658522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Italian version of the Yale-Brown Obsessive Compulsive Scale-Second Edition (Y-BOCS-II) in a clinical sample.
    Melli G; Avallone E; Moulding R; Pinto A; Micheli E; Carraresi C
    Compr Psychiatry; 2015 Jul; 60():86-92. PubMed ID: 25842194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.